Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD

Abstract Current clinical guidelines suggest methylphenidate (MPH) as first-line option for treatment of attention-deficit/hyperactivity disorder (ADHD). However, the Lombardy ADHD Registry initiative has recently raised some concerns about discrepant therapeutic approaches between different clinica...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Alessandro Crippa, Eleonora Rosi, Valentina Mauri, Angela Valli, Maria Nobile, Antonio Salandi, Sara Trabattoni, Massimo Molteni
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2025-07-01
Цуврал:	Scientific Reports
Нөхцлүүд:	Attention-deficit/hyperactivity disorder Autism spectrum disorders Comorbidity Methylphenidate Childhood Adolescents
Онлайн хандалт:	https://doi.org/10.1038/s41598-025-10684-w
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!